logo

Health News

Share SHARE
CVS-Vending-Machines-091217.jpg CVS Pharmacy will be launching health and wellness vending machines across the country to offer healthy snacks, personal care items as well as over-the-counter products to the customers on the go. The automated machines will be placed in airports, hotels, transportation hubs etc. and can be accessed using credit and debit cards. Aug2017-072717.jpg We are well into the second half of 2017. Now, let's take a look at the biotech stocks awaiting word from the FDA in August. untreatable-gonorrhea-071017.jpg There is a growing concern among the medical experts on the spread of antibiotic resistant and untreatable gonorrhea. More
tomato-112116.jpg Women who engage in yo-yo dieting may face a greater risk of heart disease, such as coronary heart disease and sudden cardiac death, according to a new study. The study, presented at the American Heart Association's Scientific Sessions 2016, featured 158,063 postmenopausal women split into four categories: stable weight, steady gain, maintained weight loss, and weight cycling. More

Bristol-Myers Says FDA Expands Approval Of Sprycel



Bristol-Myers Squibb Co. (BMY) announced the U.S. Food and Drug Administration (FDA) has expanded the indication for Sprycel or dasatinib tablets to include the treatment of children with Philadelphia chromosome-positive or Ph+ chronic myeloid leukemia or CML in chronic phase or CP. The approval for...
More
BillGates-CuringAlzheimers-111317.jpg

Bill Gates Gives Big Donation To Fight Alzheimer's



Billionaire and Microsoft co-founder Bill Gates is making a personal investment of $50 million into the Dementia Discovery Fund, a venture capital fund that invests in projects and companies to develop treatments for the brain-wasting disease. The investment is not part of Gates' philanthropic Bill & Melinda Gates Foundation, which has focused primarily on infectious diseases.
More
Slide0-Alzheimers-081717.jpg

Race For A New Alzheimer's Drug



The development of Alzheimer's drugs has been marred by a high failure rate. A U.S. study, which analyzed how the Alzheimer's clinical trials fared during the period of 2002 to 2012, revealed a failure rate of 99.6% compared to a failure rate of 81% for cancer drugs.
More




Follow RTT
FDA Calendar
Event DateSymbolDrug NameEvent Name
02/14/18AMAG, AMAGMakena subcutaneous auto-injector (sNDA)FDA decision on subcutaneous version of Makena to reduce the risk of preterm birth
01/24/18SGYPTRULANCE (sNDA)FDA decision on TRULANCE for the treatment of adults with irritable bowel syndrome with constipation
01/12/18LGNDLUXTURNA (BLA)FDA decision on LUXTURNA for inherited retinal disease
01/12/18ONCELUXTURNA (BLA)FDA decision on LUXTURNA for treatment of patients with vision loss due to confirmed biallelic RPE65 mutation-associated retinal dystrophy.
01/10/18LLYAbemaciclib (NDA)FDA decision on Abemaciclib for the treatment of advanced breast cancer
01/07/18XENTSINUVA implant (NDA)FDA decision on SINUVA implant for patients with recurrent ethmoid sinus obstruction
More FDA Calendar Data

FDA Device Approval
No Records Found
More FDA Device Approval Data